Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Moderna ends development of CMV vaccine after trial failure
04:34pm, Wednesday, 22'nd Oct 2025
Moderna said on Wednesday it will discontinue development of its experimental vaccine to prevent cytomegalovirus, a common cause of birth defects, after it failed to meet the main goal of a late-stage
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
04:05pm, Wednesday, 22'nd Oct 2025
Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate an
Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.
01:10pm, Wednesday, 22'nd Oct 2025
Moderna's shares have been southbound for the past few years due to unimpressive financial results. However, progress with the pipeline could significantly boost the stock over the next five years.
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
05:05am, Tuesday, 21'st Oct 2025
"Buying the dip" can be a double-edged sword for investors. Sometimes they can seize the opportunity by purchasing an oversold stock, but other times, that stock is trending lower for a good reason (a
Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025
08:00am, Sunday, 19'th Oct 2025
CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe
Moderna Vs BioNTech: Who's Winning The Post-COVID Race
09:30am, Saturday, 18'th Oct 2025
Moderna and BioNTech were the main 'saviors' of people and economies from COVID-19. However, since the pandemic ended, their stock prices have fallen by more than 70%. Recognizing this, BioNTech and M
Moderna, Inc. (MRNA) Shareholder/Analyst Call Transcript
04:06pm, Friday, 17'th Oct 2025
Moderna, Inc. (NASDAQ:MRNA ) Shareholder/Analyst Call October 17, 2025 12:00 PM EDT Company Participants Kyle Holen Lavina Talukdar - Senior VP & Head of Investor Relations Conference Call Participant
Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
07:00am, Thursday, 16'th Oct 2025
CAMBRIDGE, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to r
Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note
06:51pm, Tuesday, 14'th Oct 2025
In the closing of the recent trading day, Moderna (MRNA) stood at $26.25, denoting a -1.83% move from the preceding trading day.
Moderna: Q3 Earnings Preview - I Fear A Halloween Horror Show (Downgrade)
04:57pm, Tuesday, 14'th Oct 2025
Moderna, Inc. faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited pipeline progress. Moderna's cost-cutting measures and cash reserves provide
Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients
10:52am, Monday, 13'th Oct 2025
Moderna Inc. (NASDAQ:MRNA) announced on Sunday that its clinical, safety, and translational data from its Phase 1/2 study evaluating mRNA-4359 in combination with pembrolizumab in patients with checkp
mRNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial CAMBRIDGE, MA / ACCESS Newswire / October 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that clinical, safety an
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
06:51pm, Wednesday, 08'th Oct 2025
In the closing of the recent trading day, Moderna (MRNA) stood at $27.92, denoting a +2.12% move from the preceding trading day.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Monday, 06'th Oct 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Moderna (MRNA) Beats Stock Market Upswing: What Investors Need to Know
06:51pm, Thursday, 02'nd Oct 2025
Moderna (MRNA) concluded the recent trading session at $28.38, signifying a +2.83% move from its prior day's close.
